NewsNew UK Cannabinoid Vehicle Unveils Its Global...

New UK Cannabinoid Vehicle Unveils Its Global Ambitions Following US CBD Acquisition


AN ambitious London-headquartered private-equity acquisition vehicle has debuted with the purchase of a US CBD firm – as it sets out its  global ‘buy-and-build’ ambitions.

Tenacious Labs says the acquisition of Denver-based CBD brand Press Pause in a cash-and-shares deal sets it on the way to becoming a leading global consumer cannabinoid brand.

Further acquisitions will be announced in the ‘coming days’, says Tenacious and these will be supported by the impending launch of two UK CBD brands; Walker & Morland, and Hoo Raa.

Tenacious is headquartered in London with offices in Miami and Colorado and led by CEO Nicholas Morland and CCO Adrian Clarke.

World-Leading Business

The duo also head-up Delarki, a search fund aimed at early-stage and discretionary-spend businesses, targeting Gen Y millennials and the Gen Z student population.

Mr Clarke said: “This is a really important step in our strategy to become one of the world’s leading cannabinoid businesses operating an unrivalled portfolio of international brands.

“As consumer attitudes to cannabinoids change, we see enormous potential for value creation within the industry.”

Co-founded in 2018 by Dawn Fable, Press Pause creates premium CBD products for women’s wellbeing, including CBD balms, bath bombs, tinctures and full-spectrum CBD capsules. 

‘Major Milestone’

Ms Fable, who has joined Tenacious Labs as Head of Pause Lifestyle Brands, said: “We’ve been really encouraged by the levels of consumer interest and feedback that we’ve received to date for our female-focused products. 

Dawn Fable

“I’m now looking forward to working with Tenacious Labs to take the Press Pause brand to the next level as part of its international growth strategy.”

Mr Morland said: “I am delighted to welcome Press Pause to the Tenacious Labs group and look forward to working with Dawn and her team. 

“Our first acquisition; this is a major milestone in our strategy of building and developing a global portfolio of consumer cannabinoid brands. It brings an established US brand to the UK as the market enters its next phase of growth and consolidation.

“We have a pipeline of acquisition opportunities ahead of us, and expect to announce further developments in the near future.”

Mr Morland is a qualified chartered accountant with significant experience in private equity, and Mr Clarke has extensive understanding of the international spirits and premium discretionary spend arena. 

The global CBD market is growing rapidly and set to be worth several billion pounds over the coming years.

Analysts believe that, with thousands of CBD brands currently in the market there is room for consolidation vehicles with UK firm South West Brands recently mapping out its plans for the market segment.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you